These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1321584)

  • 1. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation.
    Reznick AZ; Kagan VE; Ramsey R; Tsuchiya M; Khwaja S; Serbinova EA; Packer L
    Arch Biochem Biophys; 1992 Aug; 296(2):394-401. PubMed ID: 1321584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.
    Packer L; Valenza M; Serbinova E; Starke-Reed P; Frost K; Kagan V
    Arch Biochem Biophys; 1991 Aug; 288(2):533-7. PubMed ID: 1654837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Eur Surg Res; 1992; 24(6):349-55. PubMed ID: 1338045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts.
    Cui J; Das DK; Bertelli A; Tosaki A
    Mol Cell Biochem; 2003 Dec; 254(1-2):227-34. PubMed ID: 14674702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector.
    Vanella A; Russo A; Acquaviva R; Campisi A; Di Giacomo C; Sorrenti V; Barcellona ML
    Cell Biol Toxicol; 2000; 16(2):99-104. PubMed ID: 10917565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
    Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
    Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.
    Löster H; Keller T; Grommisch J; Gründer W
    Mol Cell Biochem; 1999 Oct; 200(1-2):93-102. PubMed ID: 10569188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia.
    Dobsak P; Courderot-Masuyer C; Zeller M; Vergely C; Laubriet A; Assem M; Eicher JC; Teyssier JR; Wolf JE; Rochette L
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):651-9. PubMed ID: 10547080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischaemia-reperfusion.
    Katoh S; Toyama J; Kodama I; Akita T; Abe T
    J Mol Cell Cardiol; 1992 Nov; 24(11):1267-75. PubMed ID: 1336063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts.
    Williams RE; Zweier JL; Flaherty JT
    Circulation; 1991 Mar; 83(3):1006-14. PubMed ID: 1847847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
    Ferrari R; Ceconi C; Cargnoni A; Pasini E; Boffa GM; Curello S; Visioli O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():57-65. PubMed ID: 2031872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts.
    Di Lisa F; Menabò R; Barbato R; Siliprandi N
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H455-61. PubMed ID: 8067396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
    Shug A; Paulson D; Subramanian R; Regitz V
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():77-83. PubMed ID: 2031875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion.
    Mister M; Noris M; Szymczuk J; Azzollini N; Aiello S; Abbate M; Trochimowicz L; Gagliardini E; Arduini A; Perico N; Remuzzi G
    Kidney Int; 2002 Mar; 61(3):1064-78. PubMed ID: 11849462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine.
    Menasché P; Grousset C; Mouas C; Piwnica A
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):13-21. PubMed ID: 2366551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine reduces the reperfusion injury in isolated neonatal rabbit hearts after hypothermic preservation.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Surg Today; 1993; 23(5):424-9. PubMed ID: 8391884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-propionyl-carnitine protection of mitochondria in ischemic rat hearts.
    Di Lisa F; Menabò R; Siliprandi N
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):169-73. PubMed ID: 2779536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the reperfused heart by L-propionylcarnitine.
    Leipälä JA; Bhatnagar R; Pineda E; Najibi S; Massoumi K; Packer L
    J Appl Physiol (1985); 1991 Oct; 71(4):1518-22. PubMed ID: 1757378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.